Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

3 High-Yield Dividend Stocks to Buy in 2025


High-yield dividend stocks may not appeal to some investors. However, if you're among those investors looking for income, stocks that pay dividends regularly can be great additions to your portfolio.

Three Motley Fool contributors have identified some especially great high-yield dividend stocks to buy in 2025 -- and all of them are big pharma stocks. Here's why they chose (NYSE: ABBV), Amgen (NASDAQ: AMGN), and Pfizer (NYSE: PFE).

Keith Speights (AbbVie): Income investors should like AbbVie's forward dividend yield of 3.68%. However, they should absolutely love the big drugmaker's dividend track record. AbbVie has increased its dividend for 52 years, putting it in the elite group of stocks known as Dividend Kings.

Continue reading


Source Fool.com

AbbVie Inc. Stock

€191.00
0.320%
The AbbVie Inc. stock is trending slightly upwards today, with an increase of €0.60 (0.320%) compared to yesterday's price.
With 38 Buy predictions and not a single Sell prediction AbbVie Inc. is an absolute favorite of our community.
With a target price of 209 € there is a slightly positive potential of 9.42% for AbbVie Inc. compared to the current price of 191.0 €.
Like: 0
Share

Comments